24/7 Emergency & General Advisory
🚨 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM – 6:00 PM, Mon–Sat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Why does one heavy smoker develop lung cancer while another never does? Researchers have long suspected inherited genetics plays a role in cases like this, but proving it directly in humans has been nearly impossible given how much lifestyles and environments differ. A new mouse study from the Unive
Most smokers never develop lung cancer. Some people who've never touched a cigarette do. It's one of those facts that unsettles people when they first hear it, and researchers have suspected for decades that inherited genetics is part of the explanation. Proving that directly, though, has been genuinely difficult, since real people's lives are full of confounding variables, diet, other exposures, geography, that make it nearly impossible to isolate genetics as the cause.
A new study, published in the journal Nature, gets around that problem in a clever way: by controlling everything except genetics. The research grew out of a multi-year collaboration involving the University of Cambridge, the University of Edinburgh, and institutions across Europe and the US, co-led by Professor Duncan Odom, Dr. Sarah Aitken, and Professor Martin Taylor.
The researchers' solution was to move the question into mice, where environment can actually be held constant. They bred four strains of mice with different levels of natural susceptibility to liver cancer, chosen so that, together, the strains represented a level of genetic diversity roughly comparable to what's found across human populations.
Every mouse then received the exact same single dose of a liver carcinogen called diethylnitrosamine, or DEN, at exactly the same age, 15 days old, under carefully controlled lab conditions. DEN is a compound found in tobacco smoke and some processed foods, and it damages DNA in liver cells in a way that can trigger tumor growth. Because every variable except genetic background was held constant, any differences in outcome could be attributed to genetics rather than lifestyle or exposure differences.
The team sequenced the genomes of nearly 600 tumors that developed across the four mouse strains, and separately tracked how often tumors formed spontaneously, without DEN exposure, in each strain. From there, they reconstructed how each tumor evolved, starting from its original triggering mutation.
Here's the interesting part. Almost every tumor, regardless of strain, ended up activating the same broad cancer-promoting signaling system, known as the MAPK pathway, a set of molecular signals that governs how cells grow and specialize. So in one sense, the tumors all arrived at a similar biological destination.
But how they got there varied significantly by genetic background. The specific driver mutations that kicked off each tumor differed strain by strain, and those differences rippled outward, changing the activity of other cancer-related pathways too. Some genetic backgrounds also showed a striking tendency toward whole-genome duplication, an event where a cell's entire set of chromosomes gets copied, which is itself a significant driver of cancer evolution in many tumor types.
Professor Odom, who led the work while at the Cancer Research UK Cambridge Institute and is now based at the German Cancer Research Center in Heidelberg, summarized it plainly: cancer doesn't arise entirely by chance, and while tumors often reach a similar biological endpoint, an individual's genetic background shapes the specific path to that endpoint.
In clinical practice, this is often the piece that's genuinely hard to explain to patients and families: why two people with seemingly identical risk factors, same smoking history, same environment, same age, can end up with completely different outcomes. This research offers real, controlled evidence for something that's long been suspected clinically but rarely demonstrated this directly, that inherited genetic differences meaningfully shape both cancer risk and how a cancer develops once it starts.
Dr. Sarah Aitken, first author on the study and now an Assistant Professor at Yale School of Medicine, pointed to the practical implication: if genetic background shapes both cancer risk and how tumors evolve, future cancer prevention and screening strategies may need to account for inherited genetics and the genetic diversity found across human populations, rather than applying the same risk models to everyone.
There's a related implication for treatment too. Many cancer treatments, including chemotherapy, work partly by damaging DNA in cancer cells. If a person's inherited genetic background shapes how their cells respond to DNA damage in the first place, it stands to reason that it could also shape how they respond to treatments that use the same basic mechanism, which strengthens the broader case for more individualized approaches to diagnosis and treatment.
This needs to be said clearly, since the study's real strength, controlling every variable except genetics, is also exactly what limits how directly it applies to human patients today. This is mouse research, using a liver-specific carcinogen in a controlled lab setting. Human cancer risk involves the same basic genetics-and-DNA-damage interaction, but layered with far more variability in exposure, lifestyle, and genetic diversity than any mouse study can fully capture.
Cancer Research UK's Dr. Sam Godfrey, whose organization helped fund the research, put it well: the study offers a fascinating hint that inherited genes may strongly influence how cancers develop after DNA damage, but more research is still needed to understand exactly what this means in humans. That's an honest, appropriately cautious read of where the science currently stands.
This doesn't change current cancer screening guidelines, genetic counseling practices, or treatment approaches. It does add real scientific weight to the argument that inherited genetics deserves more attention in how future screening and treatment strategies get designed. Current diagnostic tools, including imaging methods like MRI, remain the basis for how cancer is actually detected and monitored today.
Chemotherapy Explained: Understanding This Vital Cancer Treatment
Can an MRI Detect Cancer? Understanding Its Role in Diagnosis
Understanding Myeloproliferative Disorders: Causes, Symptoms, and Treatment
Understanding Bone Cancer: Symptoms, Causes, and When to Seek Help
Visit Hospital
Near You
Find verified endocrinologists in Lucknow on DOCTAR. Compare experience, ratings, consultation fees and hospital locations, then book an appointment online.
August 22, 2026
Hormonal problems can affect weight, blood sugar, periods, energy levels, growth and several other parts of health. A hormone specialist, usually an endocrinologist, evaluates conditions involving the body's hormone-producing glands.
August 22, 2026
Find and book verified family doctors (general physicians) in Kolkata. Compare 327 doctors by fees (₹200–₹1,500), experience, ratings and hospital affiliation. Same-day appointments available with 316 doctors. Consultations in English, Hindi and Bengali.
August 22, 2026